smooth muscle contractility; myosin light-chain phosphorylation; calcium/calmodulin-dependent protein kinase II; phorbol esters; protein kinase C IT IS WIDELY ACCEPTED that the primary regulatory pathway for smooth muscle contraction is through the Ca 2ϩ and calmodulin-dependent, reversible phosphorylation of the 20,000-Da myosin light chain (MLC 20 ) (19) . However, a number of studies suggest that additional modulatory pathways exist that may modify the activities of regulatory enzymes and/or the properties of regulatory proteins involved in the development or maintenance of contractile force. For example, the Ca 2ϩ sensitivity of MLC 20 phosphorylation and force can be altered by the regulation of myosin light-chain kinase (MLCK) (29, 33) and/or MLC 20 phosphatase activities (13) . Also, during tonic force maintenance, the relationship between force and MLC 20 phosphorylation levels can be modified or even dissociated (4, 8, 17) . Thus secondary regulatory pathways are likely to be functionally important in the control of smooth muscle contractility. Ca 2ϩ /calmodulin-dependent protein kinase II (CaM kinase II) is a ubiquitous multifunctional serine/ threonine kinase that has been implicated in the regulation of diverse cellular proteins or functions including synaptic transmission, gene transcription and cell growth, ion channels and transporters, and hormone production (3) . CaM kinase II is expressed in vascular smooth muscle as multimers of ␥-and/or ␦-subunits (24, 28, 36) . Whereas much of the kinase activity in differentiated smooth muscle can be readily extracted and is expected to be cytosolic (27) , a substantial fraction is resistant to extraction and is associated with a particulate fraction enriched in myofibrils (11, 25, 27) where several potential substrates, such as MLC 20 (6) , MLCK (11, 33) , calponin (35) , and caldesmon (12, 25) are found.
Phosphorylation of MLCK by CaM kinase II in vitro (11) , as well as in cultured tracheal smooth muscle cells (32, 33) , has been shown to reduce its sensitivity to calmodulin. Conversely, selective CaM kinase II inhibitors have been shown to increase the Ca 2ϩ sensitivity of MLC 20 phosphorylation and potentiate MLC 20 phosphorylation in cultured tracheal smooth muscle cells (32, 33) . Phosphorylation of MLCK has been documented following activation of intact swine carotid smooth muscle (34) . However, the role of CaM kinase II or the physiological consequences of this phosphorylation event were not clear in that study.
Therefore, the first goal of this study was to determine if CaM kinase II was activated in intact arterial smooth muscle in response to physiological contractile stimuli. The second goal was to determine whether CaM kinase II activation could be correlated with modulation of contractile responses. For example, if CaM kinase II is activated and phosphorylates MLCK in response to contractile stimuli, then this should result in a feedback decrease in the Ca 2ϩ sensitivity of MLCK and attenuation of MLC 20 phosphorylation and force development. If so, inhibition of CaM kinase II should lead to enhanced force development through an increase in MLC 20 phosphorylation. To test this, we used KN-93, a selective CaM kinase II inhibitor that acts through inhibition of calmodulin binding to the kinase (30) .
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The results of this study indicate that CaM kinase II undergoes rapid activation in arterial smooth muscle, the magnitude of which is dependent on the physiological stimulus applied. A low suprabasal activation of the kinase is maintained during tonic contraction. KN-93 pretreatment inhibited CaM kinase II activation. Unexpectedly, the CaM kinase II inhibitor KN-93 inhibited contractile force maintenance in response to physiological stimuli, whereas phorbol 12,13-dibutyrate (PDBu)-induced contractile responses were unaffected. The inhibitory effect of KN-93 on tonic force maintenance could not be explained by nonspecific inhibition of MLCK activity or by decreased phosphorylation of MLC 20 . These data are consistent with a predominantly positive role for CaM kinase II in the regulation of tonic force maintenance in response to physiological stimuli in arterial smooth muscle.
METHODS
Tissue preparation. Swine carotid arteries were obtained from a local abattoir and transported to the laboratory in ice-cold physiological salt solution (PSS: 140 mM NaCl, 4.7 mM KCl, 1.2 mM Na 2 HPO 4 , 2.0 mM MOPS, pH 7.0, 0.02 mM Na 2 EDTA, 1.6 mM CaCl 2 , 1.2 mM MgSO 4 , 1 g/l dextrose). After removing adventitial and intimal layers, circumferential medial strips (ϳ2 mm wide, 6-9 mm long, ϳ0.2 mm thick, 1-2 mg dry wt) were dissected.
Force measurement. Tissues were mounted between plastic clips (Harvard Apparatus) in water jacketed tissue baths in oxygenated PSS at 37°C. Force development was recorded isometrically using Grass FT03 force-displacement transducers, Gould model 13-4615-50 transducer amplifiers, and an eight-channel Gould polygraph, or more recently, using Harvard Apparatus isometric force transducers coupled to an eight-channel Biopac computerized data acquisition system with AcqKnowledge 3.5 software. Forces are normalized to the force induced by 110 mM KCl at the optimal length for force development (L o ) for each tissue. After equilibration and determination of L o , tissues were stimulated and frozen either with liquid N 2 -cooled tongs (for measurement of CaM kinase II activity), or in a 6% TCA/acetone/dry ice slurry (for the measurement of CaM kinase II autophosphorylation and MLC phosphorylation).
CaM kinase II activity assay. The basis and specificity of the assay for CaM kinase II have been previously documented (1, 10) . Activation of the kinase is inferred through an increase in the tissue extracts of Ca 2ϩ /calmodulin-independent (or ''autonomous'') activity assayed with a specific peptide substrate (autocamtide 2; KKALRRQETVDAL) of CaM kinase II. This increase in autonomous activity is dependent on a specific autophosphorylation event (threonine-287 in ␦-and ␥-subunits) that occurs between Ca 2ϩ /calmodulin (Ca 2ϩ / CaM)-activated subunits within the multimeric holoenzyme (3, 23) and is preserved during extraction of the kinase from intact tissues by inclusion of phosphatase inhibitors.
Frozen tissues were stored in liquid N 2 , then pulverized in liquid N 2 -cooled stainless steel vials (Crescent Dental) in the following solution: 50 mM MOPS, 1% Nonidet P-40, 100 mM sodium pyrophosphate, 100 mM NaF, 250 mM NaCl, 3 mM EGTA, 1 mM 1,4-dithiothreitol (DTT), 0.23 U/ml aprotinin, 0.1 mM phenylmethylsulfonyl fluoride, 1 µg/ml leupeptin, 2 µg/ml trypsin inhibitor, and 2 µM microcystin LR. Homogenates were thawed on ice and centrifuged at 17,000 g for 15 min at 4°C. Autocamtide 2 kinase activity was assayed in a total volume of 25 µl containing 50 mM HEPES (pH 7.4), 10 mM magnesium-acetate, 0.2 mM [␥-32 P]ATP (specific activity 440 cpm/pmol), 20 µM autocamtide 2, plus 1 mM EGTA (for assay of autonomous, Ca 2ϩ /CaM-independent activity) or 600 nM calmodulin and 0.8 mM CaCl 2 (for assay of total activity). Assays were carried out at 30°C, started by the addition of lysate (2-4 µg total protein), and stopped at 2 min by spotting aliquots onto P-81 phosphocellulose paper squares. P-81 papers were washed exhaustively in 75 mM phosphoric acid, followed by a wash in ethanol, then dried. Bound radioactivity was counted in a liquid scintillation counter. Protein concentrations were determined using the Lowry method. Total and autonomous CaM kinase II activities were calculated in nanomoles of P i incorporated in autocamtide 2 per minute per milligram lysate protein. Autonomous activity, a measure of the activation state of CaM kinase II, was reported as a percentage of total activity measured in the same extract. Under these conditions, kinase activity assays were linear up to 7 min and over a range of 0-6 µg total protein/assay. To ensure that the reactions were enzyme limited, the concentration of autocamtide 2 was set at a sixfold excess based on the highest measured kinase activity.
Myosin light-chain phosphorylation measurements. Frozen tissues were thawed at room temperature, air-dried, and then homogenized on ice in glass-to-glass homogenizers (Radnoti, Monrovia, CA) in a buffer consisting of 10% glycerol, 1% SDS and 1 mM DTT at 6 mg dry wt/ml. Homogenates were subjected to isoelectric focusing (pH 4.5-5.4), followed by SDS-PAGE in the second dimension (26) . Gels were stained with Coomassie brilliant blue R-250 and analyzed using a Molecular Dynamics laser densitometer. Data are expressed as a ratio of phosphorylated MLC over total (phosphorylated plus unphosphorylated) MLC (only smooth muscle specific light-chain isoforms were evaluated).
Chemicals. Microcystin LR, KN-92, KN-93, and KN-62 were purchased from Calbiochem (La Jolla, CA), or from Seikagaku America (Rockville, MD), PDBu from Alexis (San Diego, CA), and [␥-32 P]adenosine trisphosphate from Amersham (Arlington Heights, IL). All other chemicals were of reagent grade and were obtained from standard suppliers. KN-93 was dissolved in deionized H 2 O (Seikagaku) or in DMSO (Calbiochem). Microcystin LR, KN-92, KN-62, and PDBu were dissolved in DMSO. Stock solutions were diluted into PSS so that the concentration of DMSO did not exceed 0.3% (with the exception of KN-62, where to achieve a 30 µM concentration in the working salt solutions, as much as 10% DMSO was required), and control specimens were incubated with identical concentrations of the vehicle.
RESULTS
Ca 2ϩ /calmodulin-independent or autonomous CaM kinase II activity depends on the magnitude of autophosphorylation (on threonine-286) in response to activation by Ca 2ϩ /calmodulin. Autonomous activity can be preserved and measured in cell or tissue extracts containing phosphatase inhibitors, providing an index of CaM kinase II activation (1, 10) . As shown in the left panel of Fig. 1 , autonomous CaM kinase II activity, expressed as a percentage of total CaM kinase II activity, was low (3.7 Ϯ 0.9%, n ϭ 15) in unstimulated arterial strips, consistent with low levels of free intracellular Ca 2ϩ in the resting muscles. Physiological contractile stimuli (1 µM histamine and membrane depolarization with 110 mM KCl) triggered rapid increases in autonomous CaM kinase II activity in tissue extracts indicative of CaM kinase II activation in situ.
The early time course and magnitude of CaM kinase II activation was stimulus specific. Depolarization-induced autonomous CaM kinase II activity levels were only slightly elevated after 10 s and peaked at 20 s, whereas histamine-induced autonomous CaM kinase II activity was maximal by 10 s. Autonomous activity stimulated by 110 mM KCl rarely exceeded 30% of total activity (28.8 Ϯ 7.1%), whereas autonomous activity generated in response to histamine averaged 73.7 Ϯ 13.4% of the total activity. CaM kinase II activation in response to either stimulus declined to suprabasal levels by 60 s (26.6 Ϯ 7.9% and 24.7 Ϯ 5.2% for histamine and KCl stimulation, respectively) and remained significantly elevated even after 70 min during tonic contractions (Fig. 1, right) .
To infer whether CaM kinase II was involved in regulating contractile activity, we tested the effect of KN-93, a selective CaM kinase II inhibitor in vitro (2, 30) , on activation of CaM kinase II and force development in the intact tissues. Treatment of tissues with KN-93 inhibited KCl-and histamine-induced CaM kinase II activation and generation of autonomous activity with an IC 50 of ϳ1 µM (Fig. 2) , comparable with IC 50 values reported using purified enzymes (30) . These results are similar to the effects of KN-93 on CaM kinase II activation in cultured vascular smooth muscle cells (1) . Preincubation for 30 min with 1-100 µM KN-93 inhibited KCl depolarization-induced force development and maintenance in a dose-dependent manner (Fig. 3, A and C) . Early force development was significantly attenuated and tonic force maintenance (after 70 min) was completely inhibited in the presence of 30 µM KN-93 (Fig. 3, A and C) . In contrast, the early phase of histamine-induced force development was virtually unaffected by as much as 30 µM KN-93 (Fig. 3, B and D) , whereas again tonic force maintenance after 70 min was nearly eliminated. The inhibitory effect of KN-93 on tonic force could not be readily reversed by repeated washes of either KCl-or histamine-stimulated tissues, although phasic force responses could still be elicited (data not shown). The IC 50 for KN-93 inhibition of tonic KCl-induced (Fig. 4A ) or histamine-induced (Fig. 4B ) tonic force response was ϳ3-5 µM. Addition of 30 µM KN-93 after maximal force had developed in response to either KCl depolarization or histamine also resulted in a slow relaxation of the tissues with similar kinetics for each stimulus (Fig. 5) .
In control experiments, preincubation with KN-92, which is an inactive analog of KN-93 with respect to inhibition of CaM kinase II activation (2, 30), had only a weak inhibitory effect on tonic KCl-or histamineinduced force maintenance over the same range of KN-93 concentrations that maximally relaxed the tissues (Fig. 4) . Adding it to precontracted tissues also had no effect (not shown). A second CaM kinase II inhibitor, KN-62 (33), was evaluated in this system. However, addition of as much as 30 µM KN-62 had no significant inhibitory effect on either contractile stimulus-induced CaM kinase II activation or force development (not shown). Concentrations of KN-62 in excess of 30 µM in PSS resulted in obvious precipitation unless the concentration of the vehicle, DMSO, was raised to ϳ6-10%, a concentration of DMSO that is in itself deleterious to these tissues. It appears that the lack of a significant effect of KN-62 on CaM kinase II is due to poor solubility and/or permeability in these relatively thick arterial preparations.
Because it is well established that MLC 20 phosphorylation is required for and is the primary determinant of force development in smooth muscle in response to physiological stimuli, we evaluated the effects of KN-93 on this parameter. Figure 6A shows that 30 µM KN-93 inhibited peak MLC 20 phosphorylation at 1 min of KCl depolarization (50.7 Ϯ 7.8% control vs. 21.3 Ϯ 6.0% in the presence of KN-93), consistent with its inhibitory effect on rapid force development with this stimulus (Fig. 3, A and C) . However, by 5 min there was no significant difference between MLC 20 phosphorylation values from control and KN-93-treated tissues (21.6 Ϯ 4.4% vs. 22.4 Ϯ 2.0%) while force was inhibited by ϳ70% at this time (Fig. 3C) . MLC 20 phosphorylation values during tonic KCl-induced contractions (70 min) were unaffected by 30 µM KN-93. In histaminestimulated tissues, 30 µM KN-93 had no inhibitory effect on MLC 20 phosphorylation at early or late time points (Fig. 6B) . Overall, these data indicate that the inhibition of tonic force maintenance in either KCldepolarized or histamine-stimulated tissues by KN-93 cannot be simply explained by nonspecific inhibition of MLCK catalyzed MLC 20 phosphorylation.
Phorbol ester activators of protein kinase C stimulate contraction in carotid arterial smooth muscle by an unknown mechanism that appears to be largely or totally independent of MLC 20 phosphorylation (7, 26) on those residues (serine-19 or threonine-18) whose phosphorylation is otherwise considered both necessary and sufficient for actin-activated myosin ATPase (reviewed in Ref. 19 ). Interestingly, force development or maintenance in response to 1 µM PDBu was unaffected by pretreatment with up to 100 µM KN-93 (Fig.  7) , concentrations of KN-93 that completely inhibited tonic force in response to the physiological activators. This observation confirms the unique properties of a phorbol ester-induced contractile response and suggests that pharmacological activation of protein kinase C can circumvent the requirement for physiological activation of CaM kinase II during activation of arterial smooth muscle.
DISCUSSION
Our current understanding of CaM kinase II function in smooth muscle is limited and mostly based on data from smooth muscle cell culture models where it has been linked to regulation of cell motility (21), modulation of MLCK activity (32, 33) , and activation of the mitogen-activated protein kinase signaling pathway (2, 20) . In the present study, we have documented CaM kinase II activation in an intact smooth muscle preparation in response to prototypical contractile stimuli, and based on a pharmacological approach, provided evidence that CaM kinase II may be involved in regulating smooth muscle contractility.
The assay for in situ CaM kinase II activation used in this study measures accumulation of the Ca 2ϩ -independent or autonomous form of CaM kinase II that results from autophosphorylation of a threonine residue conserved in all CaM kinase II subunits (threonine-287 in CaM kinase II ␦-and ␥-subunits) (3). Although this autophosphorylation event is not required for Ca 2ϩ / calmodulin-dependent activity of the kinases (10, 23) , it provides the kinase with unique functional properties that may be of physiological importance. For example, calmodulin binding affinity is increased by almost three orders of magnitude in the autophosphorylated kinase (18) . These autoregulatory properties may result in a prolongation of kinase activity following a transient Ca 2ϩ signal and provide the kinase with the property of responding to Ca 2ϩ transients in a frequency-dependent manner (5) . Irrespective of the functional importance of the autophosphorylated form of the kinase, its appearance in a tissue provides an index of the state of CaM kinase II activation because the autophosphorylation only occurs between Ca 2ϩ /calmodulin-bound (activated) subunits within the holoenzyme (10, 23) . However, there are at least two factors that impinge on the fidelity of the assay from the standpoint of estimating Ca 2ϩ /calmodulin-dependent CaM kinase II activation in situ. One is that the amount of autonomous activity measured in the assay reflects net autophosphorylation on threonine-287 and is therefore also dependent on in situ phosphatase activities. The other factor is that the autophosphorylation reaction requires at least two activated subunits per holoenzyme and it is cooperative (1, 23) . Thus the assay would be predicted to underestimate the extent of Ca 2ϩ /calmodulin-dependent CaM kinase II activation in situ, particularly at submaximal [Ca 2ϩ ] i levels and/or when phosphatase activities are high. The low levels of autonomous activity that were measured during tonic contraction in response to either histamine or KCl are consistent with a predicted low, but suprabasal, free intracellular [Ca 2ϩ ] and these assay limitations.
Although smooth muscle CaM kinase II has a lower affinity for calmodulin (ϳ10 nM) (27; unpublished observations) compared with MLCK (ϳ1 nM) (29) , our data from cultured vascular smooth muscle cells (1) and intact arterial tissues (this study) strongly argue that, under physiological conditions, neither [Ca 2ϩ ] i nor free calmodulin was a limiting factor in the activation of the kinase. The observed histamine-stimulated increase in autonomous activity, which reached 73% of the total CaM kinase II activity within 10 s, is one of the highest values of autonomous CaM kinase II reported in any intact cell or tissue. Because autonomous CaM kinase II activity rarely exceeds 80% of total activity in vitro, even under optimal autophosphorylation conditions (28) , it can be inferred that 1 µM histamine results in a nearly complete activation of CaM kinase II in the intact tissues.
Based on previous reports using this tissue and Ca 2ϩ indicators to determine concentrations of free intracel- lular Ca 2ϩ , 1 µM histamine and 110 mM KCl would have been predicted to stimulate comparable increases in [Ca 2ϩ ] (9). In fact, the kinetics of MLC 20 phosphorylation and force generation in response to these stimuli were found in the present study to be similar, consistent with this prediction. In contrast to these similarities, KCl depolarization resulted in a significantly slower and smaller increase in autonomous CaM kinase II activity compared with 1 µM histamine. Recent developments in our understanding of the spatial distribution of [Ca 2ϩ ] i (22) , as well as data suggesting that calmodulin is compartmentalized and liberated during stimulation (15, 32) , may help explain the high level of CaM kinase II activation we observed in response to histamine in arterial smooth muscle. It appears that in both the carotid artery and cultured vascular smooth muscle cells (1) , agents that release Ca 2ϩ from internal stores very efficiently activate CaM kinase II, consistent with a kinase pool located in the proximity of the sarco/endoplasmic reticulum where locally high concentrations of free Ca 2ϩ would be expected.
In previous studies reporting effects of the CaM kinase II inhibitor, KN-62, in cultured tracheal smooth muscle cells, it was concluded that CaM kinase II phosphorylation of MLCK decreases MLCK sensitivity to Ca 2ϩ /calmodulin and attenuates stimulus-induced MLC 20 phosphorylation responses (32, 33) . In the present study, we reasoned that if this mechanism was functionally significant in intact carotid artery, then inhibition of CaM kinase II with KN-93, a more soluble analog of KN-62, should potentiate MLC 20 phosphorylation and force development in response to contractile stimuli. In contrast to the prediction, there was no potentiation of MLC 20 phosphorylation or force by KN-93. This result, coupled with the lack of correlation between CaM kinase II activation levels and parameters of MLC 20 phosphorylation and force in histamineand KCl-stimulated tissues, suggests that CaM kinase II is not an important regulator of force development in intact carotid arterial smooth muscle. Our results are also consistent with the previously observed lack of correlation between MLCK phosphorylation levels and net MLC 20 phosphorylation and force in the same tissue (34) .
The predominant effect of KN-93 on contractile force responses in carotid artery is during sustained force maintenance and the effect is inhibitory, suggesting a positive role for CaM kinase II during this period. The fact that addition of KN-93 to tonically contracted tissues results in relaxation (Fig. 5) indicates that the early phase of CaM kinase II activation is not related to its apparent role during force maintenance. We considered the possibility that the effects of KN-93 were due to nonspecific inhibition of MLCK activity, either directly by inhibiting Ca 2ϩ /calmodulin binding or indirectly by interfering with availability of free intracellular Ca 2ϩ . The major arguments against this are: 1) KN-93 is not an effective inhibitor of smooth muscle MLCK in vitro (30) , 2) KN-93 potencies for inhibiting histamine-and KCl-stimulated increases in autonomous CaM kinase II activity and tonic force maintenance are similar, and 3) neither the transient increases in histamine-stimulated force and MLC 20 phosphorylation nor sustained MLC 20 phosphorylation in response to KCl or histamine were inhibited by KN-93. Because KN-93 had no effect on PDBu-induced contractile responses, a similar argument can be made that it did not nonspecifically inhibit protein kinase C. However, in the case of KCl-depolarization, KN-93 did attenuate early increases in MLC 20 phosphorylation and force. These data could be interpreted to indicate that KN-93 has a nonspecific inhibitory effect on Ca 2ϩ entry through plasmalemmal Ca 2ϩ channels, or, alternatively, that KN-93 is acting specifically on Ca 2ϩ entry through such channels. There are reports in the literature that indicate a role for CaM kinase II in mediating Ca 2ϩ -dependent facilitation of Ca 2ϩ entry through voltage-dependent Ca 2ϩ channels in smooth muscle (16) and in heart (14) .
Although we do not yet fully understand the underlying mechanism(s), the data reported here indicate a KN-93-induced dissociation of MLC 20 phosphorylation and force in tonically contracted arterial smooth muscle. The results are qualitatively similar to other studies that also demonstrated inhibition of force with sustained suprabasal levels of MLC 20 phosphorylation in smooth muscle following addition of okadaic acid (31), nitroprusside (17) , high Mg 2ϩ concentrations (4), or by a manipulation of extracellular Ca 2ϩ concentrations during agonist stimulation (8) . In a general sense, the maintenance of disproportionately high MLC 20 phosphorylation levels in the face of decreasing force is consistent with the idea that tonic maintenance of smooth muscle force, i.e., the ''latch'' state (19) , involves regulatory mechanisms in addition to those affecting MLC 20 phosphorylation.
Assuming that KN-93 specifically inhibits CaM kinase II, our data are consistent with the existence of an unidentified CaM kinase II-dependent phosphorylation event that is required for tonic force maintenance in arterial smooth muscle. If this model is correct, then regulation of both force development through MLCK activation and force maintenance through CaM kinase II would be primarily dependent on intracellular free [Ca 2ϩ ]. Based on the PDBu-induced contractile responses that are both MLC 20 phosphorylation independent (7, 26) and KN-93 insensitive, it appears that pharmacological activation of protein kinase C can circumvent the physiological requirements for MLCK and CaM kinase II activation. To the extent that protein kinase C is activated physiologically, it could function in parallel with or in place of CaM kinase II to support force maintenance. It is reasonable to speculate that both CaM kinase II and protein kinase C, as multifunctional protein kinases, could share a common substrate or set of substrates. Potentially relevant substrates for the kinases from the standpoint of regulating smooth muscle contraction include thinfilament-associated regulatory proteins such as caldesmon or calponin, proteins required for transmission of force through actomyosin/cytoskeleton attachment sites,
